193 related articles for article (PubMed ID: 23541807)
1. ErbB3 silencing reduces osteosarcoma cell proliferation and tumor growth in vivo.
Jullien N; Dieudonné FX; Habel N; Marty C; Modrowski D; Patino A; Lecanda F; Sévère N; Marie PJ
Gene; 2013 May; 521(1):55-61. PubMed ID: 23541807
[TBL] [Abstract][Full Text] [Related]
2. FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
Brun J; Dieudonné FX; Marty C; Müller J; Schüle R; Patiño-García A; Lecanda F; Fromigué O; Marie PJ
PLoS One; 2013; 8(1):e55034. PubMed ID: 23383046
[TBL] [Abstract][Full Text] [Related]
3. CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis.
Fromigue O; Hamidouche Z; Vaudin P; Lecanda F; Patino A; Barbry P; Mari B; Marie PJ
J Bone Miner Res; 2011 Jul; 26(7):1533-42. PubMed ID: 21312266
[TBL] [Abstract][Full Text] [Related]
4. Cyr61 silencing reduces vascularization and dissemination of osteosarcoma tumors.
Habel N; Vilalta M; Bawa O; Opolon P; Blanco J; Fromigué O
Oncogene; 2015 Jun; 34(24):3207-13. PubMed ID: 25065593
[TBL] [Abstract][Full Text] [Related]
5. PKD1 negatively regulates cell invasion, migration and proliferation ability of human osteosarcoma.
Onishi Y; Kawamoto T; Kishimoto K; Hara H; Fukase N; Toda M; Harada R; Kurosaka M; Akisue T
Int J Oncol; 2012 Jun; 40(6):1839-48. PubMed ID: 22426824
[TBL] [Abstract][Full Text] [Related]
6. Targeting the E3 ubiquitin casitas B-lineage lymphoma decreases osteosarcoma cell growth and survival and reduces tumorigenesis.
Sévère N; Dieudonné FX; Marty C; Modrowski D; Patiño-García A; Lecanda F; Fromigué O; Marie PJ
J Bone Miner Res; 2012 Oct; 27(10):2108-17. PubMed ID: 22623369
[TBL] [Abstract][Full Text] [Related]
7. The downregulation of miR-144 is associated with the growth and invasion of osteosarcoma cells through the regulation of TAGLN expression.
Zhao M; Huang J; Gui K; Xiong M; Cai G; Xu J; Wang K; Liu D; Zhang X; Yin W
Int J Mol Med; 2014 Dec; 34(6):1565-72. PubMed ID: 25318625
[TBL] [Abstract][Full Text] [Related]
8. Neuregulin/erythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to invasion and early recurrence of human hepatoma.
Hsieh SY; He JR; Hsu CY; Chen WJ; Bera R; Lin KY; Shih TC; Yu MC; Lin YJ; Chang CJ; Weng WH; Huang SF
Hepatology; 2011 Feb; 53(2):504-16. PubMed ID: 21246584
[TBL] [Abstract][Full Text] [Related]
9. Tissue factor associates with survival and regulates tumour progression in osteosarcoma.
Tieken C; Verboom MC; Ruf W; Gelderblom H; Bovée JV; Reitsma PH; Cleton-Jansen AM; Versteeg HH
Thromb Haemost; 2016 May; 115(5):1025-33. PubMed ID: 26763081
[TBL] [Abstract][Full Text] [Related]
10. Silencing LPAATβ inhibits tumor growth of cisplatin-resistant human osteosarcoma in vivo and in vitro.
Song L; Duan P; Gan Y; Li P; Zhao C; Xu J; Zhang Z; Zhou Q
Int J Oncol; 2017 Feb; 50(2):535-544. PubMed ID: 28035350
[TBL] [Abstract][Full Text] [Related]
11. TRIM2 regulates the development and metastasis of tumorous cells of osteosarcoma.
Qin Y; Ye J; Zhao F; Hu S; Wang S
Int J Oncol; 2018 Oct; 53(4):1643-1656. PubMed ID: 30066883
[TBL] [Abstract][Full Text] [Related]
12. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
Tu B; Du L; Fan QM; Tang Z; Tang TT
Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
[TBL] [Abstract][Full Text] [Related]
13. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo.
Ho PW; Goradia A; Russell MR; Chalk AM; Milley KM; Baker EK; Danks JA; Slavin JL; Walia M; Crimeen-Irwin B; Dickins RA; Martin TJ; Walkley CR
Oncogene; 2015 May; 34(22):2922-33. PubMed ID: 25043296
[TBL] [Abstract][Full Text] [Related]
15. Amphiregulin enhances intercellular adhesion molecule-1 expression and promotes tumor metastasis in human osteosarcoma.
Liu JF; Tsao YT; Hou CH
Oncotarget; 2015 Dec; 6(38):40880-95. PubMed ID: 26503469
[TBL] [Abstract][Full Text] [Related]
16. The cyclooxygenase-2 inhibitor NS-398 inhibits proliferation and induces apoptosis in human osteosarcoma cells via downregulation of the survivin pathway.
Duan DP; Dang XQ; Wang KZ; Wang YP; Zhang H; You WL
Oncol Rep; 2012 Nov; 28(5):1693-700. PubMed ID: 22922684
[TBL] [Abstract][Full Text] [Related]
17. Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential.
Techavichit P; Gao Y; Kurenbekova L; Shuck R; Donehower LA; Yustein JT
BMC Cancer; 2016 Nov; 16(1):869. PubMed ID: 27821163
[TBL] [Abstract][Full Text] [Related]
18. Depletion of ALX1 causes inhibition of migration and induction of apoptosis in human osteosarcoma.
Yang M; Pan Y; Zhou Y
Tumour Biol; 2015 Aug; 36(8):5965-70. PubMed ID: 25736924
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of TRAF4 expression suppresses osteosarcoma cell growth in vitro and in vivo.
Yao W; Wang X; Cai Q; Gao S; Wang J; Zhang P
Int J Mol Med; 2014 Dec; 34(6):1655-60. PubMed ID: 25270078
[TBL] [Abstract][Full Text] [Related]
20. DRP5 is involved in cancer cell growth and predicts poor prognosis in human osteosarcoma.
Wang L; Liu W; Tang H; Xie X; Zou C; Wang Y; Gao Z; Yin J
Cancer Med; 2017 May; 6(5):982-993. PubMed ID: 28374915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]